$852 Million is the total value of Eversept Partners, LP's 62 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 71.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AMRN | Buy | AMARIN CORP PLCspons adr new | $77,965,744 | +73.8% | 15,943,915 | +49.7% | 9.15% | -8.2% |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $69,616,358 | +186.1% | 458,636 | +90.4% | 8.17% | +51.1% |
| ALXN | New | ALEXION PHARMACEUTICALS INC | $58,777,488 | – | 376,200 | +100.0% | 6.90% | – |
| TGTX | Sell | TG THERAPEUTICS INC | $44,937,529 | +64.1% | 863,851 | -15.6% | 5.27% | -13.4% |
| AZN | Buy | ASTRAZENECA PLCsponsored adr | $42,613,026 | +1176.1% | 852,431 | +1298.9% | 5.00% | +573.7% |
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $38,840,894 | -17.7% | 530,976 | -12.6% | 4.56% | -56.6% |
| FATE | Sell | FATE THERAPEUTICS INC | $36,326,444 | +69.9% | 399,499 | -25.3% | 4.26% | -10.3% |
| GSK | Buy | GLAXOSMITHKLINE PLCsponsored adr | $35,196,522 | +1334.7% | 946,581 | +1370.5% | 4.13% | +657.6% |
| ASND | Buy | ASCENDIS PHARMA A/Ssponsored adr | $31,195,032 | +25.6% | 187,043 | +16.2% | 3.66% | -33.7% |
| CTLT | Buy | CATALENT INC | $29,087,877 | +142.0% | 279,503 | +99.2% | 3.41% | +27.7% |
| NVST | New | ENVISTA HOLDINGS CORPORATION | $29,053,504 | – | 861,355 | +100.0% | 3.41% | – |
| DHR | Buy | DANAHER CORPORATION | $28,082,373 | +315.5% | 126,330 | +302.8% | 3.29% | +119.3% |
| TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $26,520,613 | +22.9% | 2,748,250 | +14.8% | 3.11% | -35.1% |
| AVTR | New | AVANTOR INC | $25,916,298 | – | 920,650 | +100.0% | 3.04% | – |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $23,637,416 | +8773.0% | 138,644 | +7208.6% | 2.77% | +4600.0% |
| ANTM | New | ANTHEM INC | $21,118,410 | – | 65,771 | +100.0% | 2.48% | – |
| ZGNX | Buy | ZOGENIX INC | $18,185,063 | +17.2% | 909,708 | +5.1% | 2.13% | -38.1% |
| QGEN | Buy | QIAGEN NV | $17,803,157 | +103.4% | 336,862 | +101.1% | 2.09% | +7.4% |
| ENSG | Sell | ENSIGN GROUP INC | $15,213,890 | -16.5% | 208,470 | -34.6% | 1.78% | -55.9% |
| DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $14,052,917 | -31.9% | 246,240 | -38.8% | 1.65% | -64.1% |
| GSK | New | GLAXOSMITHKLINE PLCcall | $12,975,680 | – | 352,600 | +100.0% | 1.52% | – |
| ITCI | Buy | INTRA CELLULAR THERAPIES INC | $11,328,273 | +149.8% | 356,235 | +101.5% | 1.33% | +31.8% |
| TARO | Buy | TARO PHARMACEUTICAL INDS LTD | $11,178,636 | +43.6% | 152,256 | +7.3% | 1.31% | -24.2% |
| HSKA | Sell | HESKA CORP | $11,093,578 | -29.3% | 76,166 | -52.0% | 1.30% | -62.7% |
| KDMN | New | KADMON HLDGS INC | $9,996,873 | – | 2,408,885 | +100.0% | 1.17% | – |
| BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO L | $8,893,612 | -57.5% | 103,764 | -67.7% | 1.04% | -77.5% |
| MGLN | New | MAGELLAN HEALTH INC | $8,673,348 | – | 104,700 | +100.0% | 1.02% | – |
| RAD | New | RITE AID CORP | $8,421,623 | – | 532,004 | +100.0% | 0.99% | – |
| AUPH | Buy | AURINIA PHARMACEUTICALS INC | $8,358,409 | +30.1% | 604,368 | +38.6% | 0.98% | -31.3% |
| MCRB | New | SERES THERAPEUTICS INC | $8,184,201 | – | 334,049 | +100.0% | 0.96% | – |
| QDEL | Buy | QUIDEL CORP | $7,290,736 | +255.7% | 40,583 | +334.4% | 0.86% | +87.9% |
| AMRN | Buy | AMARIN CORP PLCcall | $6,285,606 | +18.1% | 1,285,400 | +1.7% | 0.74% | -37.6% |
| AFMD | Sell | AFFIMED N V | $5,614,595 | +33.0% | 964,707 | -22.5% | 0.66% | -29.7% |
| AMRX | Sell | AMNEAL PHARMACEUTICALS INC | $5,384,159 | -47.8% | 1,178,153 | -55.6% | 0.63% | -72.4% |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $5,374,714 | +56.6% | 307,742 | +4.9% | 0.63% | -17.3% |
| ALT | New | ALTIMMUNE INC | $4,286,400 | – | 380,000 | +100.0% | 0.50% | – |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $3,664,297 | -6.7% | 491,852 | -57.0% | 0.43% | -50.7% |
| FPRX | New | FIVE PRIME THERAPEUTICS INC | $3,557,727 | – | 209,155 | +100.0% | 0.42% | – |
| SNY | Buy | SANOFIsponsored adr | $3,310,825 | +32.6% | 68,138 | +36.9% | 0.39% | -30.1% |
| HCA | Sell | HCA HEALTHCARE INC | $2,755,363 | -57.8% | 16,754 | -68.0% | 0.32% | -77.8% |
| PRTA | Buy | PROTHENA CORP PLC | $2,441,969 | +24.1% | 203,328 | +3.2% | 0.29% | -34.6% |
| SESN | SESEN BIO INC | $2,105,762 | -3.6% | 1,559,824 | 0.0% | 0.25% | -49.1% | |
| ANAB | New | ANAPTYSBIO INC | $1,899,181 | – | 88,334 | +100.0% | 0.22% | – |
| SRDX | New | SURMODICS INC | $1,797,332 | – | 41,299 | +100.0% | 0.21% | – |
| ONCT | New | ONCTERNAL THERAPEUTICS INC | $1,686,041 | – | 344,090 | +100.0% | 0.20% | – |
| OTIC | Sell | OTONOMY INC | $1,638,741 | -1.9% | 253,283 | -38.6% | 0.19% | -48.2% |
| AUTL | New | AUTOLUS THERAPEUTICS PLCspon ads | $1,385,530 | – | 154,981 | +100.0% | 0.16% | – |
| CNCE | CONCERT PHARMACEUTICALS INC | $1,312,399 | +28.7% | 103,829 | 0.0% | 0.15% | -32.2% | |
| New | CATABASIS PHARMACEUTICALS IN | $1,117,170 | – | 522,042 | +100.0% | 0.13% | – | |
| XGN | New | EXAGEN INC | $1,077,160 | – | 81,603 | +100.0% | 0.13% | – |
| DXCM | New | DEXCOM INC | $914,318 | – | 2,473 | +100.0% | 0.11% | – |
| TARA | PROTARA THERAPEUTICS INC | $879,065 | +43.9% | 36,310 | 0.0% | 0.10% | -24.3% | |
| IQV | New | IQVIA HLDGS INC | $731,909 | – | 4,085 | +100.0% | 0.09% | – |
| A | New | AGILENT TECHNOLOGIES INC | $589,725 | – | 4,977 | +100.0% | 0.07% | – |
| GOCO | Buy | GOHEALTH INC | $405,497 | +137.1% | 29,685 | +126.1% | 0.05% | +26.3% |
| KALV | Sell | KALVISTA PHARMACEUTICALS INC | $359,386 | -73.4% | 18,925 | -82.4% | 0.04% | -86.0% |
| LCI | Sell | LANNET INCcall | $353,622 | -44.4% | 63,900 | -47.8% | 0.04% | -70.9% |
| MRUS | New | MERUS N V | $253,221 | – | 14,445 | +100.0% | 0.03% | – |
| ZYME | New | ZYMEWORKS INC | $255,440 | – | 5,405 | +100.0% | 0.03% | – |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $218,275 | -91.1% | 3,816 | -95.3% | 0.03% | -95.2% |
| CYTK | New | CYTOKINETICS INCcall | $207,800 | – | 10,000 | +100.0% | 0.02% | – |
| CYH | New | COMMUNITY HEALTH SYS INC NEW | $95,141 | – | 12,805 | +100.0% | 0.01% | – |
| Exit | TELIGENT INC NEW | $0 | – | -305,423 | -100.0% | -0.05% | – | |
| SCPH | Exit | SCPHARMACEUTICALS INC | $0 | – | -65,605 | -100.0% | -0.11% | – |
| Exit | SOLID BIOSCIENCES INC | $0 | – | -307,024 | -100.0% | -0.14% | – | |
| LQDA | Exit | LIQUIDIA TECHNOLOGIES INC | $0 | – | -182,751 | -100.0% | -0.20% | – |
| CLDX | Exit | CELLDEX THERAPEUTICS INC NEW | $0 | – | -150,494 | -100.0% | -0.50% | – |
| MRSN | Exit | MERSANA THERAPEUTICS INC | $0 | – | -140,000 | -100.0% | -0.58% | – |
| MYL | Exit | MYLAN NV | $0 | – | -324,951 | -100.0% | -1.07% | – |
| MNTA | Exit | MOMENTA PHARMACEUTICALS INC | $0 | – | -98,501 | -100.0% | -1.15% | – |
| MODN | Exit | MODEL N INC | $0 | – | -188,967 | -100.0% | -1.48% | – |
| FLDM | Exit | FLUIDIGM CORP DEL | $0 | – | -1,302,353 | -100.0% | -2.15% | – |
| OSUR | Exit | ORASURE TECHNOLOGIES INC | $0 | – | -940,412 | -100.0% | -2.54% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMARIN CORP PLC | 21 | Q3 2023 | 12.5% |
| DANAHER CORPORATION | 21 | Q3 2023 | 8.1% |
| AFFIMED N V | 20 | Q3 2023 | 0.9% |
| ARGENX SE | 19 | Q3 2023 | 2.0% |
| GSK PLC | 18 | Q2 2022 | 13.1% |
| ASCENDIS PHARMA A/S | 18 | Q1 2022 | 7.7% |
| SANOFI | 18 | Q4 2022 | 7.2% |
| ENSIGN GROUP INC | 18 | Q1 2022 | 8.6% |
| CENTENE CORP DEL | 18 | Q3 2023 | 1.5% |
| ZOGENIX INC | 17 | Q4 2021 | 12.4% |
View Eversept Partners, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cabaletta Bio, Inc. | February 14, 2023 | 282,874 | 1.0% |
| Teligent, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| Teligent, Inc. | February 14, 2020 | 4,501,799 | 8.4% |
View Eversept Partners, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
View Eversept Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.